Arsenic enhances the apoptosis induced by interferon gamma: key role of IRF-1

J El Bougrini1, M Pampin, M K Chelbi-Alix

  • 1UPR CNRS 9045, Institut André Lwoff 7 rue Guy Moquet, 94801 Villejuif, France.

Insights

Interferons (IFNs) and arsenic trioxide synergize to inhibit cancer cell growth. This combination prolongs STAT1 activation, increasing IRF-1 expression, which drives anti-proliferative effects and apoptosis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cellular Signaling

Background:

  • Interferons (IFNs) and arsenic trioxide (As2O3) are established inhibitors of cell proliferation with applications in malignancy treatment.
  • IFNgamma signaling involves STAT1 phosphorylation, dimerization, nuclear translocation, DNA binding, and gene transcription.

Purpose of the Study:

  • To investigate the synergistic effects of IFNgamma and As2O3 on STAT1 phosphorylation and IRF-1 expression in human fibrosarcoma cells.
  • To elucidate the role of IRF-1 in mediating the anti-proliferative and pro-apoptotic effects of this combination therapy.

Main Methods:

  • Utilized the human fibrosarcoma cell line 2fTGH.
  • Administered IFNgamma and As2O3, alone and in combination.
  • Assessed STAT1 phosphorylation, DNA binding to GAS motifs, IRF-1 expression, cell proliferation, and apoptosis.
  • Employed RNA interference to down-regulate IRF-1 expression.

Main Results:

  • As2O3 prolonged IFNgamma-induced STAT1 phosphorylation, leading to sustained STAT1 binding to GAS motifs.
  • This resulted in significantly increased IRF-1 expression.
  • The enhanced IRF-1 expression correlated with increased anti-proliferative effects and apoptosis.
  • Down-regulation of IRF-1 abolished the biological responses induced by IFNgamma and As2O3.

Conclusions:

  • The combination of IFNgamma and As2O3 exhibits synergistic anti-cancer activity in fibrosarcoma cells.
  • Sustained STAT1 activation and subsequent IRF-1 upregulation are critical mediators of these synergistic effects.
  • IRF-1 plays a key role in mediating the anti-proliferative and pro-apoptotic outcomes of this therapeutic combination.

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...